ArticleJAMA network open2026
Health Status Changes and Long-Term Clinical Outcomes in Patients With Atrial Fibrillation.
Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Improving health status, including symptoms and quality of life, is a key goal in the management of atrial fibrillation (AF). However, whether improvements in patient-reported health status are associated with subsequent clinical outcomes remains unclear. Objective: To evaluate the association between changes in health status and long-term adverse clinical outcomes in patients with AF. Design, Setting, and Participants: This cohort study used data from a prospective multicenter registry in Japan that enrolled patients aged 22 to 94 years with newly diagnosed AF or who were newly referred for AF management between September 20, 2012, and May 22, 2018. The registry collected follow-up data for up to 5 years. Eligible patients completed the Atrial Fibrillation Effect on Quality of Life patient-reported outcome measure (PROM) questionnaire at both baseline and 1-year follow-up. Clinical outcomes were assessed for 4 years following the 1-year AF PROM assessment. Data were analyzed between February 7 and July 14, 2025. Exposure: One-year change in the AF PROM overall summary score. Main Outcomes and Measures: The primary outcome was a composite of all-cause death, heart failure hospitalization, and stroke or transient ischemic attack over 4 years. Multivariable hierarchical regression models adjusted for baseline score, clinical factors, and comorbidities were used to evaluate associations between 1-year change in AF PROM overall summary score and outcomes. Results: Among 2744 patients (mean [SD] age, 67.8 [11.1] years; 1868 male [68.1%]; 1357 [49.6%] with paroxysmal AF), 1408 (51.3%) had improved health status (overall summary score increase of ≥5 points), 833 (30.4%) had stable health status, and 503 (18.3%) had worsened health status (overall summary score decrease of ≥5 points). During a mean (SD) follow-up of 3.1 (1.4) years after the 1-year assessment, the primary outcome occurred in 283 patients (10.3%). After adjustment for baseline characteristics (including baseline AF PROM score), improvement in the AF PROM overall summary score was associated with a lower risk of adverse outcomes (per 5-point increase: hazard ratio, 0.93 [95% CI, 0.89-0.96]; P < .001). Conclusions and Relevance: This cohort study of patients with AF in Japan found that greater improvements in 1-year AF PROM scores were associated with a lower risk of subsequent adverse clinical events. These findings support the prognostic value of PROMs and highlight the importance of monitoring health status in AF management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.